Characterization of compound missense mutation and deletion of carnitine palmitoyltransferase II in a patient with adenovirus-associated encephalopathy
スポンサーリンク
概要
- 論文の詳細を見る
Background : In mammals, carnitine palmitoyltransferase (CPT) system is a pivotalcomponent of energy metabolism through mitochondrial fatty acid oxidation. The majorityof patients with fatal or handicapped influenza-associated encephalopathy exhibitthermolabile compound homo/heterozygous mutations of CPT II. Objective : CompoundCPT II mutations, [c.647A G (p.Q216R)], [c.1102G A (p.V368I)], [c.1939A G (p.M647V)]and [c.745delG (p.G249EfsX16)], were found in a patient with adenovirus-associated encephalopathyand his family. The properties of these CPT II mutations were analyzed inCOS-7 cells. Methods : CPT II mutations in the patient and his family were expressed inCOS-7 cells and their molecular masses, enzyme activities, thermal instabilities and halfliveswere analyzed. Results : We identified two novel CPT II mutations in the patient,[c.647A G (p.Q216R)] and [c.745delG (p.G249EfsX16)]. The CPT II Q216R mutation showedmild reduction of activity, thermal instability and short half-life but compound mutationswith Q216R+V368I+M647V showed further enhancement of these disabilities, althoughmutations V368I and M647V had no such effects. CPT II mutation [c.745delG (p.G249EfsX16)] abolished enzyme activity and showed short half-life. Conclusion : The thermalinstability and short half-life of the novel CPT II mutations, [c.647A G (p.Q216R)] and[c.745delG (p.G249EfsX16)], could play important roles in energy crisis in the pathogenesisof virus-associated encephalopathy.